AIDS-drugs makers escalate price war
An extraordinary price war is breaking out in the market for AIDS drugs in poor countries, as pharmaceuticals giants seek to blunt a growing threat from generic-drug companies and recoup some moral
An extraordinary price war is breaking out in the market for AIDS drugs in poor countries, as pharmaceuticals giants seek to blunt a growing threat from generic-drug companies and recoup some moral